The Latest Breaking News from CVS Health

An essential retail store could file for bankruptcy soon.

Shares slumped on Friday after the company and its CEO agreed to part ways. The pharmacy giant faces huge challenges. Yes, the stock is cheap, but letting it settle first may be a good idea.

New CVS unit aims to cut your prescription costs by offering alternatives to branded drugs.

The Dow Jones fell despite Walmart earnings and Cisco earnings beating views. Cathie Wood snapped up a beaten down stock. CVS stock cratered.

The stock market is not making much progress. Buffett stock plunges while Cisco leads the S&P 500.

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

Blue Shield of California will end its CVS Health prescription benefit management contract and tap Amazon to replace it.

CVS's pharmacy benefits division hauled in nearly $27 billion in second quarter revenues, offsetting concerns for a surge in medical cost payouts.

Health insurance CEOs pocket millions while citizens can’t pay the out-of-pocket.

The 2023 Fortune Most Powerful Women in Business list will publish this fall.

Special situation stocks create event-driven opportunities for investors. Here are five that are worth a closer look.